BioCentury
ARTICLE | Clinical News

Totect regulatory update

January 27, 2014 8:00 AM UTC

Kissei said Japan's Ministry of Health, Labor and Welfare (MHLW) approved an NDA for Savene dexrazoxane to treat anthracycline extravasation. The topoisomerase II (TOP2) inhibitor is marketed in the ...